Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Hamidreza Jahantigh, Nahid Ahmadi, Piero Lovreglio, Angela Stufano, Maryam Enayatkhani, Behzad Shahbazi & Khadijeh Ahmadi. (2023) Repurposing antiviral drugs against HTLV-1 protease by molecular docking and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics 41:11, pages 5057-5066.
Read now
Read now
C. Tremblay, B. Trottier, A. Rachlis, J.G. Baril, M. Loutfy, R. Lalonde, J.S. Sampalis & F. Boulerice. (2011) Treatment Durability, Effectiveness, and Safety with Atazanavir/Ritonavir-Based HAART Regimen in Treatment-Naïve HIV-lnfected Patients. HIV Clinical Trials 12:3, pages 151-160.
Read now
Read now
Antonio Mastrolorenzo, Stefano Rusconi, Andrea Scozzafava & Claudiu T Supuran. (2006) Inhibitors of HIV-1 protease: 10 years after. Expert Opinion on Therapeutic Patents 16:8, pages 1067-1091.
Read now
Read now
Barreiro Pablo, Rendón Ana, Rodríguez-Nóvoa Sonia & Soriano Vincent. (2005) Atazanavir: The Advent of a New Generation of More Convenient Protease Inhibitors. HIV Clinical Trials 6:1, pages 50-61.
Read now
Read now
Articles from other publishers (40)
Kai Fan Cheng, Sonya VanPatten, Mingzhu He & Yousef Al-Abed. (2022) Azapeptides -A History of Synthetic Milestones and Key Examples. Current Medicinal Chemistry 29:42, pages 6336-6358.
Crossref
Crossref
Taťána Majerová & Jan Konvalinka. (2022) Viral proteases as therapeutic targets. Molecular Aspects of Medicine 88, pages 101159.
Crossref
Crossref
Ahmad Altiti, Mingzhu He, Sonya VanPatten, Kai Fan Cheng, Umair Ahmed, Pui Yan Chiu, Ibrahim T. Mughrabi, Bayan Al Jabari, Ronald M. Burch, Kirk R. Manogue, Kevin J. Tracey, Betty Diamond, Christine N. Metz, Huan Yang, LaQueta K. Hudson, Stavros Zanos, Myoungsun Son, Barbara Sherry, Thomas R. Coleman & Yousef Al-Abed. (2022) Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidates. Nature Communications 13:1.
Crossref
Crossref
Lvyin Zheng, Xiaoya Zhuo, Yihan Wang, Xiaoying Zou, Yumei Zhong & Wei Guo. (2022)
Photocatalytic cross-dehydrogenative coupling reaction toward the synthesis of
N
,
N
-disubstituted hydrazides and their bromides
. Organic Chemistry Frontiers 9:11, pages 3012-3021.
Crossref
Crossref
Weiqi Cai, Xuelong Qiao, Hao Zhang, Bo Li, Jianhua Guo, Liangliang Zhang, Wen-Wen Chen & Baoguo Zhao. (2021) Asymmetric biomimetic transamination of α-keto amides to peptides. Nature Communications 12:1.
Crossref
Crossref
Kalpita Baruah, Biswajit Sahariah, Sushil S. Sakpal, Jugal Kishore Rai Deka, Arun Kumar Bar, Sayan Bagchi & Bani Kanta Sarma. (2021)
Stabilization of Azapeptides by N
amide
···H–N
amide
Hydrogen Bonds
. Organic Letters 23:13, pages 4949-4954.
Crossref
Crossref
Jeremy D. Baker, Rikki L. Uhrich, Gerald C. Kraemer, Jason E. Love & Brian C. Kraemer. (2021) A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease. PLOS ONE 16:2, pages e0245962.
Crossref
Crossref
Kota Miyata, Airi Narita, Ryota Fujisawa, Makoto Roppongi, Satoshi Ito, Tamesue Shingo & Toru Oba. (2020) Synthesis of boronophenylalanine-like aza-amino acids for boron-containing azapeptide precursors. Tetrahedron Letters 61:49, pages 152585.
Crossref
Crossref
Chandrashekhar Voshavar. (2019) Protease Inhibitors for the Treatment of HIV/AIDS: Recent Advances and Future Challenges. Current Topics in Medicinal Chemistry 19:18, pages 1571-1598.
Crossref
Crossref
Bani Tamraz, Yong Huang, Audrey L. French, Seble Kassaye, Kathryn Anastos, Marek J. Nowicki, Stephen Gange, Deborah R. Gustafson, Peter Bacchetti, Ruth M. Greenblatt, Pirro G. Hysi & Bradley E. Aouizerat. (2018) A Genome-Wide Association Study Identifies a Candidate Gene Associated With Atazanavir Exposure Measured in Hair. Clinical Pharmacology & Therapeutics 104:5, pages 949-956.
Crossref
Crossref
Maria Concetta Postorino, Mattia Prosperi, Emanuele Focà, Eugenia Quiros-Roldan, Elisa Di Filippo, Franco Maggiolo, Alberto Borghetti, Nicoletta Ladisa, Massimo Di Pietro, Andrea Gori, Laura Sighinolfi, Angelo Pan, Nicola Mazzini & Carlo Torti. (2017) Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort. BMC Infectious Diseases 17:1.
Crossref
Crossref
Amrita Banerjee & Samir Mitragotri. (2017) Intestinal patch systems for oral drug delivery. Current Opinion in Pharmacology 36, pages 58-65.
Crossref
Crossref
Michael Morgen, Ajay Saxena, Xue-Qing Chen, Warren Miller, Richard Nkansah, Aaron Goodwin, Jon Cape, Roy Haskell, Ching Su, Olafur Gudmundsson, Michael Hageman, Anoop Kumar, Gajendra Singh Chowan, Abhijith Rao & Vinay K. Holenarsipur. (2017) Lipophilic salts of poorly soluble compounds to enable high-dose lipidic SEDDS formulations in drug discovery. European Journal of Pharmaceutics and Biopharmaceutics 117, pages 212-223.
Crossref
Crossref
Yiyuan Wang, Yingxiu Cao, Yuanxiu Li, Jiayu Jin, Jinliang Li & Hao Song. (2017) Asymmetric biosynthesis of intermediates of anti-HIV drugs. Tetrahedron: Asymmetry 28:6, pages 745-757.
Crossref
Crossref
Diego Prada-Gracia, Sara Huerta-Yépez & Liliana M. Moreno-Vargas. (2016) Application of computational methods for anticancer drug discovery, design, and optimization. Boletín Médico del Hospital Infantil de México 73:6, pages 411-423.
Crossref
Crossref
Diego Prada-Gracia, Sara Huerta-Yépez & Liliana M. Moreno-Vargas. (2016) Application of computational methods for anticancer drug discovery, design, and optimization. Boletín Médico Del Hospital Infantil de México (English Edition) 73:6, pages 411-423.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
687
736
.
Mark Berlin, Aaron Ruff, Filippos Kesisoglou, Wei Xu, Michael Hong Wang & Jennifer B. Dressman. (2015) Advances and challenges in PBPK modeling – Analysis of factors contributing to the oral absorption of atazanavir, a poorly soluble weak base. European Journal of Pharmaceutics and Biopharmaceutics 93, pages 267-280.
Crossref
Crossref
Fangfang Deng, Meihong Xie, Xiaoyun Zhang, Peizhen Li, Yueli Tian, Honglin Zhai & Yang Li. (2014) Combined molecular docking, molecular dynamics simulation and quantitative structure–activity relationship study of pyrimido[1,2-c][1,3]benzothiazin-6-imine derivatives as potent anti-HIV drugs. Journal of Molecular Structure 1067, pages 1-13.
Crossref
Crossref
Fiona V. Büdingen, Daniel Gonzalez, Amelia N. Tucker & Hartmut Derendorf. (2014) Relevance of liver failure for anti-infective agents: from pharmacokinetic alterations to dosage adjustments. Therapeutic Advances in Infectious Disease 2:1, pages 17-42.
Crossref
Crossref
Ilker Avan, C. Dennis Hall & Alan R. Katritzky. (2014) Peptidomimetics via modifications of amino acids and peptide bonds. Chemical Society Reviews 43:10, pages 3575.
Crossref
Crossref
Davis Kibirige & Richard Ssekitoleko. (2013) Endocrine and metabolic abnormalities among HIV-infected patients: A current review. International Journal of STD & AIDS 24:8, pages 603-611.
Crossref
Crossref
R M Savic, A Barrail-Tran, X Duval, G Nembot, X Panhard, D Descamps, C Verstuyft, B Vrijens, A-M Taburet, C Goujard & F Mentré. (2012) Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients. Clinical Pharmacology & Therapeutics 92:5, pages 575-583.
Crossref
Crossref
Amrita Banerjee & Hayat Onyuksel. (2012) Peptide delivery using phospholipid micelles. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 4:5, pages 562-574.
Crossref
Crossref
Hong C. Shen. 2012. Applications of Transition Metal Catalysis in Drug Discovery and Development. Applications of Transition Metal Catalysis in Drug Discovery and Development
25
95
.
Natasza E. Ziółkowska, Anna Bujacz, Ramnarayan S. Randad, John W. Erickson, Tereza Skálová, Jindřich Hašek & Grzegorz Bujacz. (2012) New Active HIV-1 Protease Inhibitors Derived from 3-Hexanol: Conformation Study of the Free Inhibitors in Crystalline State and in Complex with the Enzyme. Chemical Biology & Drug Design 79:5, pages 798-809.
Crossref
Crossref
Xiongyu Wu, Per Öhrngren, Advait A. Joshi, Alejandro Trejos, Magnus Persson, Riina K. Arvela, Hans Wallberg, Lotta Vrang, Åsa Rosenquist, Bertil B. Samuelsson, Johan Unge & Mats Larhed. (2012) Synthesis, X-ray Analysis, and Biological Evaluation of a New Class of Stereopure Lactam-Based HIV-1 Protease Inhibitors. Journal of Medicinal Chemistry 55:6, pages 2724-2736.
Crossref
Crossref
Jorge L. Martinez-Cajas & Mark A. Wainberg. 2009. Antiviral Research. Antiviral Research
113
135
.
Xing Fan, Yan-Li Song & Ya-Qiu Long. (2008) An Efficient and Practical Synthesis of the HIV Protease Inhibitor Atazanavir via a Highly Diastereoselective Reduction Approach. Organic Process Research & Development 12:1, pages 69-75.
Crossref
Crossref
Sara Colombo, Thierry Buclin, Matthias Cavassini, Laurent A. Décosterd, Amalio Telenti, Jérôme Biollaz & Chantal Csajka. (2006) Population Pharmacokinetics of Atazanavir in Patients with Human Immunodeficiency Virus Infection. Antimicrobial Agents and Chemotherapy 50:11, pages 3801-3808.
Crossref
Crossref
Luis M. F. Gonzalez, Renato S. Aguiar, Adriana Afonso, Patricia A. Brindeiro, Mônica B. Arruda, Marcelo A. Soares, Rodrigo M. Brindeiro & Amílcar Tanuri. (2006) Biological characterization of human immunodeficiency virus type 1 subtype C protease carrying indinavir drug-resistance mutations. Journal of General Virology 87:5, pages 1303-1309.
Crossref
Crossref
Elke S. Perloff, Su X. Duan, Paul R. Skolnik, David J. Greenblatt & Lisa L. von Moltke. (2005) ATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITRO. Drug Metabolism and Disposition 33:6, pages 764-770.
Crossref
Crossref
Tracy Swainston Harrison & Lesley J Scott. (2005) Atazanavir. Drugs 65:16, pages 2309-2336.
Crossref
Crossref
Peter L Anderson. (2004) Pharmacologic Perspectives for Once-Daily Antiretroviral Therapy. Annals of Pharmacotherapy 38:11, pages 1924-1934.
Crossref
Crossref
S COLOMBO, N GUIGNARD, C MARZOLINI, A TELENTI, J BIOLLAZ & L DECOSTERD. (2004) Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction. Journal of Chromatography B 810:1, pages 25-34.
Crossref
Crossref
Joanne J Orrick & Corklin R Steinhart. (2004) Atazanavir. Annals of Pharmacotherapy 38:10, pages 1664-1674.
Crossref
Crossref
Shridhar Hegde & Jeffery Carter. 2004.
335
368
.
E. Fumero & D. Podzamczer. (2003) New patterns of HIV-1 resistance during HAART. Clinical Microbiology and Infection 9:11, pages 1077-1084.
Crossref
Crossref
David R Goldsmith & Caroline M Perry. (2003) Atazanavir. Drugs 63:16, pages 1679-1693.
Crossref
Crossref
Erik De Clercq. 2003.
1
62
.